|
1) Ichikawa T, Saito K, Yoshioka N, et al. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol. 2010; 45: 133-41
|
|
|
|
2) Frericks BB, Loddenkemper C, Huppertz A, et al. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. Am J Roentgenol. 2009; 193: 1053-60
|
|
|
|
|
|
3) Narita M, Hatano E, Arizono S, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol. 2009; 44: 793-8
|
|
|
|
|
|
4) Tsuboyama T, Onishi H, Kim T, et al. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging—correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology. 2010; 255: 824-33
|
|
|
|
|
|
5) Tamada T, Ito K, Sone T, et al. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging. 2009; 29: 636-40
|
|
|
|
|
|
6) Sun HY, Lee JM, Shin CI, et al. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (＜ or ＝2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Invest Radiol. 2010; 45: 96-103
|
|
|
|
|
|
7) Motosugi U, Ichikawa T, Sou H, et al. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Radiology. 2010; 256: 151-8
|
|
|
|
|
|
8) Ahn SS, Kim MJ, Lim JS, et al. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology. 2010; 255: 459-66
|
|
|
|
|
|
9) Kim YK, Kim CS, Han YM, et al. Detection of hepatocellular carcinoma: gadoxetic acid-enhanced 3-dimensional magnetic resonance imaging versus multi-detector row computed tomography. J Comput Assist Tomogr. 2009; 33: 844-50
|
|
|
|
|
|
10) Kogita S, Imai Y, Okada M, et al. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol. 2010; 20: 2405-13
|
|
|
|
|
|
11) Lee JY, Kim SH, Jeon YH, et al. Ferucarbotran-enhanced magnetic resonance imaging versus gadoxetic acid-enhanced magnetic resonance imaging for the preoperative detection of hepatocellular carcinoma: initial experience. J Comput Assist Tomogr. 2010; 34: 127-34
|
|
|
|
|
|
12) Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology. 2000; 32: 205-12
|
|
|
|
|
|
13) Okada M, Imai Y, Kim T, et al. Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2010; 32: 903-13
|
|
|
|
|
|
14) Yoon MA, Kim SH, Park HS, et al. Value of dual contrast liver MRI at 3. 0 T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules: Preliminary results of multivariate analysis. Invest Radiol. 2009; 44: 641-9
|
|
|
|
|
|
15) Ishigami K, Yoshimitsu K, Nishihara Y, et al. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology. 2009; 250: 435-43
|
|
|
|
|
|
16) Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1. 5 T. Radiology. 2009; 251: 67-76
|
|
|
|
|
|
17) Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display—early experience. Radiology. 2005; 237: 1048-55
|
|
|
|
|
|
18) Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut. 2005; 54: 122-7
|
|
|
|
|
|
19) Patel J, Sigmund EE, Rusinek H, et al. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging. 2010; 31: 589-600
|
|
|
|
|
|
20) Hashimoto K, Murakami T, Dono K, et al. Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging. Oncol Rep. 2006; 16: 677-83
|
|
|
|
|
|
21) Tsushima Y, Funabasama S, Sanada S, et al. Perfusion changes of hepatic parenchyma due to infectious hepatobiliary disease: demonstration by perfusion CT. Comput Med Imaging Graph. 2003; 27: 289-91
|
|
|
|
|
|
22) Zhong L, Wang WJ, Xu JR. Clinical application of hepatic CT perfusion. World J Gastroenterol. 2009; 15: 907-11
|
|
|
|
|
|
23) Sahani DV, Holalkere NS, Mueller PR, et al. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. Radiology. 2007; 243: 736-43
|
|
|
|
|
|
24) Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008; 359: 378-90
|
|
|
|
|
|
25) Maksimovic O, Schraml C, Hartmann JT, et al. Evaluation of response in malignant tumors treated with the multitargeted tyrosine kinase inhibitor sorafenib: a multitechnique imaging assessment. Am J Roentgenol. 2010; 194: 5-14
|
|
|
|
|
|
26) Graser A, Johnson TR, Bader M, et al. Dual energy CT characterization of urinary calculi: initial in vitro and clinical experience. Invest Radiol. 2008; 43: 112-9
|
|
|
|
|
|
27) Johnson TR, Krauss B, Sedlmair M, et al. Material differentiation by dual energy CT: initial experience. Eur Radiol. 2007; 17: 1510-7
|
|
|
|
|
|
28) Holmes DR, 3rd, Fletcher JG, Apel A, et al. Evaluation of non-linear blending in dual-energy computed tomography. Eur J Radiol. 2008; 68: 409-13
|
|
|
|
|
|
29) Behrendt FF, Schmidt B, Plumhans C, et al. Image fusion in dual energy computed tomography: effect on contrast enhancement, signal-to-noise ratio and image quality in computed tomography angiography. Invest Radiol. 2009; 44: 1-6
|
|
|
|
|
|
30) Yanagawa M, Tomiyama N, Honda O, et al. Multidetector CT of the lung: image quality with garnet-based detectors. Radiology. 2010; 255: 944-54
|
|
|
|
|
|
31) Yeh BM, Shepherd JA, Wang ZJ, et al. Dual-energy and low-kVp CT in the abdomen. AJR Am J Roentgenol. 2009; 193: 47-54
|
|
|
|
|
|
32) Kitao A, Zen Y, Matsui O, et al. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. Radiology. 2009; 252: 605-14
|
|
|
|
|
|
33) Toyoda H, Kumada T, Sone Y. Impact of a unified CT angiography system on outcome of patients with hepatocellular carcinoma. Am J Roentgenol. 2009; 192: 766-74
|
|
|
|
|